Beste Brust Röntgen Kardiologen in Istanbul - TOP -77 Ärzte

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

EDUCATION

Balgrist University, Zurich

• Shoulder and Elbow Observership, Feb 8th - March 23rd, 2023

Bezmialem Vakif University

• Shoulder and Elbow Surgery Fellowship Program, March 1st - July 2nd, 2021

Istanbul Sisli Etfal Research and Training Hospital

• Residency, Orthopaedic Surgery, 2011-2016

Hospital for Special Surgery, USA

• Observership, May 2nd - June 30th, 2016

Istanbul University, Istanbul Faculty of Medicine

• Medical School, 2003–2009

PROFESSIONAL EXPERIENCE

Istanbul Sisli Hamidiye Etfal Research and Training Hospital

• Residency, Orthopaedic Surgery, 2011-2016

Kilis State Hospital

• Orthopaedics Surgeon, 2017-2019

Yedikule Surp Pırgiç Armenian Hospital

• Orthopaedics Surgeon, 2019-2020

Istanbul Sisli Hamidiye Etfal Research and Training Hospital

• Orthopaedics Surgeon, 2020-2024

Medipol Acıbadem Hospital

• Orthopaedics Surgeon, 2024-present

Spezialisierungen

Arthroskopisches Debridement und Mikrofrakturchirurgie

Arthroskopische Meniskektomie

Arthroskopische Rekonstruktion des vorderen Kreuzbandes

Arthroplastik (Totalgelenkprothese) Chirurgie

Knie-, Schulter-, Hüftersatzoperation

Hallux Valgus Operation (Zehenfehlstellung)

Unfallchirurgie

Exzision von Weichteiltumoren

Erfahrung

Maraş Budaklı Gesundheitszentrum 1993

Forschungskrankenhaus der Universität İnönü 1994

Kartal Ausbildungs- und Forschungskrankenhaus 1995-2000

Privates Gül Medicine Ensar Hospital 2002

Zentralkrankenhaus Gebze 2002–2010

Privates Oran Cerrah Medical Center 2010-2018

Krankenhauspark 2019-2021

Ausbildung

Medizinische Fakultät Cerrahpaşa

Medical Fields of Interest:

• Spine Surgery

• Prosthetic Surgery,

• Trauma

• Sports Medicine

Education:

• ISTANBUL UNIVERSITY Istanbul Faculty Of Medicine (1998-2004)
• ISTANBUL MEDENİYET UNIVERSITY FACULTY OF MEDICINE / SURGICAL MEDICAL SCIENCES DEPARTMENT / ORTHOPEDICS AND TRAUMATOLOGY DEPARTMENT

Experience:

• İzmir Military Hospital (Military Service 2010-2011)

• Bingöl State Hospital (Compulsory service 2011-2013)

• Istanbul Florence Nightingale Hospital (Spine surgery fellowship training 2013-2014)

• Istanbul Bilim University Faculty of Medicine Dr. Lecturer (2014-2015)

• Medicalpark Bahçelievler Hospital (2015-2021)

ch

• Türkische Gesellschaft für Orthopädie und Traumatologie, Zweigstelle Handchirurgie

• Türkische Gesellschaft für Orthopädie und Traumatologie, Zweigstelle für Wirbelsäulenchirurgie

• Türkische Gesellschaft für Orthopädie und Traumatologie, Zweigstelle für Sportverletzungen

• Türkische Gesellschaft für Orthopädie und Traumatologie, Abteilung Kinderorthopädie

Assoz. Prof. Dr. Erkam KÖMÜRCÜ ist außerordentlicher Professor für Orthopädie und Traumatologie mit Erfahrung in Lehre und Verwaltungsaufgaben. Er hat ein Board-Zertifikat der türkischen Gesellschaft für Orthopädie und Traumatologie – Trainingsrat (TOTEK) – seit 2010 und einen Titel als außerordentlicher Professor seit April 2015. Dr. Kömürcü verfügt über umfangreiche Erfahrung in den Bereichen Orthopädie und Traumatologie, Hand- und obere Extremitätenverletzungen, Frakturen und Luxationen der unteren Extremität, radiologische Untersuchung bei muskuloskelettalen Tumoren, interventionelle Hüftdysplasie, gutartige und bösartige muskuloskelettale Tumoren, Wirbelfrakturen, Kreuzschmerzen und Beckenfrakturen.

Außerordentlicher Prof. Ozgur Cicekli

Ausbildung :

Bachelor-Abschluss: 1998-2005 – Medizinische Fakultät (Englisch), Hacettepe-Universität
Facharztausbildung Ankara Atatürk Bildungs- und Forschungskrankenhaus
2005 – 2010 - Klinik für Orthopädie und Traumatologie
Titel des außerordentlichen Professors: 2019 Sakarya Unıversıty Educatıtın And Research Hospıtal

Biografie :

2005 – 2010 - Residency, Atatürk Lehr- und Forschungskrankenhaus, Ankara
2011-2012 – Militärdienst, Militärkrankenhaus Samsun
2012 – 2015 – Wehrpflicht, Sanliurfa Mehmet Akif Inan Bildungs- und Forschungskrankenhaus
2015-2020 Gesundheitsministerium Sakarya Universität Ausbildungs- und Forschungskrankenhaus
2020 – Adatip Sakarya Krankenhaus

Fachgebiet:

Schwerpunkte
Sportverletzungen und Operationen
Gelenkerhaltende Chirurgie
Arthroplastik
Orthopädische Traumatologie

Mitgliedschaften:

1. 2018, Mitglied der Türkischen Gesellschaft für Sportverletzungen, Arthroskopie und Kniechirurgie
2. 2014, Mitglied des türkischen Ausbildungsrates für Orthopädie und Traumatologie (totek)
3. 2012, Mitglied, Föderation der Türkischen Gesellschaft für Orthopädie und Traumatologie (totbid)

Kongress:

Briefe/Artikel/Veröffentlichungen
A. In internationalen Peer-Review-Zeitschriften veröffentlichte Artikel:
A.1 Çiçekli Özgür, Dogan Metin (2018). Bewertung des chirurgischen Ergebnisses bei Patienten im fortgeschrittenen Alter mit entwicklungsbedingter Hüftdysplasie. International Journal Of Surgery, 52, 44-49., Doi:
10.1016/j.ijsu.2015.02.020, (Kontrollnummer: 4920803)
A.2 Çiçekli Özgür,topçu Hüseyin Nevzat,kochai Alauddin,sükür Erhan,türker Mehmet
(2019). Vergleich der suprapatellaren und infrapatellaren Tibianagelung: Anatomischerer Eintrittspunkt und
Frakturreposition über den suprapatellaren Zugang. Internationale Zeitschrift für klinische und experimentelle
Medicine, 12(1), 804-811., Doi: Ijcem0082501, (Kontrollnummer: 4840087)
A.3 Çiçekli Özgür, özdemir Güzelali, uysal Mustafa, biçici Vedat, bingöl Izzet (2016).
Perkutane Fixierung mit kanülierter Schraube bei epiphysären Knöchelfrakturen bei Kindern. Springerplus,
5, (1) Doi: 10.1186/s40064-016-3623-1, (Kontrollnummer: 4920888)
A.4 Çiçekli Özgür, Kochai Alauddin, Sükür Erhan, Basak Ali Murat, Kurtoglu Alper, Türkermehmet (2019). Suprapatellarer Ansatz bei Frakturen der Tibia: Spielt das Frakturniveau eine Rolle?
Gelenkerkrankungen und verwandte Chirurgie, 30(1), 10-16., Doi:
10.5606/ehc.2019.63487, (Kontrollnummer: 4919692)
A.5 Çiçekli Özgür, Bingöl Izzet,tepe Nermin,akgül Turgut,çiçekli Esen, Atbinici
Hasan, Arslan Arslan Kagan (2016). Neuromuskuläre Funktionsveränderungen des Quadrizeps nach ACL-Rekonstruktion. West Indian Medical Journal, Doi: 10.7727/wimj.2015.558,
(Kontrollnummer: 4892448)
A.6 Özdemir Güzelali, Çiçekli Özgür, Akgül Turgut, Zehir Sinan, Ferit Yücel, Eskin Deniz
(2014). Die Ergebnisse von autologem Knochentransplantat und kopfloser kanülierter Titan-Kompressionsschraube zur Behandlung der Kahnbein-Pseudarthrose. Turkish Journal Of Trauma And Emergency Surgery, 20(3),
199-204., Doi: 10.5505/tjtes.2014.92255, (Kontrollnummer: 4866486)
A.7 Özdemir Güzelali, Akgül Turgut, Çiçekli Özgür, Yilmaz Baris, Atbinici Hasan, Yücel Ferit (2017). Lunatum-Exzision und Scaphocapitatum-Arthrodese bei Morbus Kienböck. Journal of Orthopaedic Surgery, 25(1), Doi: 10.1177/2309499017692704, (Kontrollnummer: 4866032)
A.8 Kochai Alauddin, Türker Mehmet, Çiçekli Özgür, Özdemir Ugur, Bayam
Levent, Erkorkmaz Ünal, Sükür Erhan (2018). Eine vergleichende Studie dreier häufig verwendeter Fixierungstechniken bei isolierter medialer Malleolusfraktur. Gelenkerkrankungen und damit verbundene Operationen,
29(2), 104-109., Doi: 10.5606/ehc.2018.61449, (Kontrollnummer: 4866101)
A.9 Sükür Erhan, Akar Abdülhalim, Topçu Hüseyin Nevzat, Çiçekli Özgür, Kochai
Alauddin, Türker Mehmet (2018). Die Wirkung von N-Acetylcystein auf die mechanische Ermüdungsresistenz von antibiotikahaltigem Knochenzement. Journal of Orthopaedic Surgery and Research, 13,
Doi: 10.1186/s13018-018-0843-9, (Kontrollnummer: 4866136)
A.10 Akgül Turgut, Zehir Sinan, Özdemir Güzelali, Yücel Ferit, Türk Abdulkadir, Çiçekli
Özgür (2014). Die Ergebnisse der Anwendung einer anatomischen Platte mit niedrigem Profil zur Behandlung von Klavikuladiaphysenfrakturen Typ 2 vom Typ Edinburg. Turkish Journal Of Trauma And Emergency Surgery, 20(4), 286-290., Doi: 10.5505/tjtes.2014.88303, (Kontrollnummer: 4866478)
A.11 Sükür Erhan, Akar Abdülhalim, Uyar Ahmet Çagri, Çiçekli Özgür, Kochai
Alauddin, Türker Mehmet, Topçu Hüseyin Nevzat (2018). Vakuumunterstützter Verschluss im Vergleich zu feuchten Verbänden bei der Behandlung diabetischer Wundgeschwüre nach partieller Fußamputation: A
Retrospektive Analyse bei 65 Patienten. Journal Of Orthopaedic Surgery, 26(3), Doi:
10.1177/2309499018799769, (Kontrollnummer: 4866083)
A.12 Yalçin Muhammed Nadir, Bektaser Süleyman Bülent, Çiçekli Özgür, Dogan Metin
(2009). Korbhenkelriss eines diskoiden Außenmeniskus bei einem 6-jährigen Mädchen. Acta Orthopaedica Et
Traumatologica Turcica, 43(6), 528-531., Doi: 10.3944/aott.2009.528, (Kontrollnummer: 4866457)
A.13 Yalçin Muhammed Nadir, Bektaser Süleyman Bülent, Çiçekli Özgür, Ugras
Serdar, Dogan Metin (2010). Eine ungewöhnliche Ursache für wiederkehrende Gelenkergüsse: Nichthämophilie
Hämosiderotische Synovitis des Knies. Acta Orthopaedica Et Traumatologica Turcica, 44(2), 162-
165, Doi: 10.3944/aott.2010.2240, (Kontrollnummer: 4866450)
B. In lokalen Peer-Review-Zeitschriften veröffentlichte Artikel:

B.1 Çiçekli Özgür (2019). Verbessern sich Schlafstörungen und Lebensqualität nach einer arthroskopischen Rotatorenmanschettenoperation? Annals Of Medical Research, 26(4), 664-669., Doi:
10.5455/annalsmedres.2019.01.049, (Kontrollnummer: 4892204)
B.2 Sükür Erhan, Uyar Ahmet Çagri, Özdemir Ugur, Gökçen Hüseyin Bahadir, Çiçekli
Özgür, Topçu Hüseyin Nevzat (2018). Beurteilung der Übereinstimmung zwischen Altersgruppe und Ätiologie, Ausmaß und Revisionen von Amputationen. Medeniyet Medical Journal, 33(1), 10-16., Doi:10.5222/mmj.2018.35002,

Zertifikat
Türkische Gesellschaft für Orthopädie und Traumatologie - Prüfung des türkischen Rates für Orthopädie und Traumatologie, Eignungsprüfung für Orthopädie und Traumatologie, 2014, Ankara, Zertifikat,
14.09.2014 -26.10.2014 (national)

Kurs
Schulterkurs Nizza, Schulterkurs, der arthroskopische und prothetische Chirurgie abdeckt. Das Programm umfasst Vorträge führender Schulterchirurgen, Diskussionsrunden, eine Live-Operationssitzung und Workshops mit Leichen und Plastikmodellen., Nizza, Kurs, 02.06.2016 -04.06.2016 (international)
2.
Ao Trauma Kurs - Fortgeschrittene Prinzipien der Frakturbehandlung, Ao Trauma Kurs - Fortgeschrittene
Grundsätze der Frakturbehandlung, Ankara, Kurs, 17.01.2015 -20.01.2015 (national)
3.
Ao Trauma Kurse- Fuß Sprunggelenk, Ao Trauma Kurse- Fuß Sprunggelenk Chirurgie, Graz, Kurs, 17.09.2014 -
19.09.2014 (international)
4.
Epos-bat Aufbaukurs, Aktuelle Konzepte in der Behandlung von Hüftgelenkserkrankungen bei Kindern., Izmir,
Lehrgang, 06.09.2013 -07.09.2013 (international)
5.
Gazi Schulterarthroskopiekurs, Schulterarthroskopiekurs, Ankara, Gazi Universitätsklinikum, Kurs
04.01.2013 05.01.2013 (national)
6.
Frakturmanagement während des Wachstums, Frakturmanagement während des Wachstums, Ao Trauma Kurse, Graz, Kurs, 12.09.2010 -12.09.2010 (international)
7.
Ao Trauma Kursansatz und Osteosynthese, Ao Trauma Kursansatz und Osteosynthese (mit Leichendissektionen), Graz, Kurs, 08.09.2010 -12.09.2010 (international)
8.
Einführungskurs mit Leichenpräparation, Einführungskurs mit Leichenpräparation für Ao Travma-Zugänge und Osteosynthese, Graz, Kurs, 07.09.2010 -07.09.2010 (international)
9.
Ao Trauma Kurs - Grundsätze der operativen Frakturbehandlung, Ao Trauma Kurs - Grundsätze der operativen Frakturbehandlung, Ankara, Kurs, 15.01.2010 -19.01.2010 (national)
10.
Ao Kindertraumakurs, Ao Kindertraumakurs, Izmir, Kurs, 18.04.2009 -19.04.2009 (national)
11.
2. Kurs für intrameduläres Nageln, Kurs für intrameduläres Nageln, 2009, Izmir, Kurs, 15.01.2009
18.01.2009 (national)
12.
Schule für Grundlagenwissenschaften und Forschung, Türkische Gesellschaft für Orthopädie und Traumatologie - Türkischer Rat für Orthopädie und Traumatologie-Ausbildung. Schule für Grundlagenwissenschaften und Forschung, Türkische Gesellschaft für Orthopädie und Traumatologie - Türkischer Rat für Orthopädie und Traumatologie-Ausbildung. Erzurum, Kurs, 27.02.2008-01.03.2008 (national)

Education

• 1992-1999 Hacettape University
• 2000-2004 Dokuz Eylül University
• 2007 Al-Azhar University
• 2009 Al-Shefa Medical Complex

Memberships

• 2016 TOAK Turkish Orthopedic Research Council
• 2015 TOTBİD
• 2005 Egyptian Orthopaedic Association EOA

Experience

• 2004-2009 Balsam Hospitals, Gaza / Palestine
• 2009-2013 AL-SHIFA Training and Research State Hospital, Gaza / Palestine
• 2007-2013 Al-Azhar University Faculty of Medicine, Gaza / Palestine
• 2014-2015 Private Karatas Hospital, Izmir / Turkey
• 2015-2016 Private Gazi Kent Surgical Medical Center, Izmir / Turkey
• 2015-2016 West Anatolia Central Hospital, Izmir / Turkey
• 2016 Catalca State Hospital, Istanbul / Turkey

I was born in Irbid in 1979. I got into Istanbul University Medical Faculty after graduating from Bani Kananah-King Hüseyin High School. I continued my education at Marmara University Medical Faculty and obtained the title of Orthopedics and Traumatology Specialist.
I worked at many private and state hospitals. I attended many courses and congresses.
I was awarded the grand prize in the branch of Sports injury and arthroscopic knee surgery of 2015 Ulusal Türk Ortopedi ve Travmatoloji Kongresi (National Turkish Orthopedics and Traumatology Congress) with the study with the title of “Mozaikoplasti Yöntemi ile Patellar Osteoid Osteoma En-blok Eksizyonu ve Kıkırdak Rekonstrüksiyonu (Patellar Osteoid Osteoma En-bloc Excision with Mosaicplasty Procedure and Cartilage Reconstruction)”.
I have nearly 10 publications.

Op. Dr. Cem SEVER ist Facharzt für Orthopädie und Traumatologie. Er hat einen Bachelor- und Master-Abschluss der Dokuz Eylül University und verfügt über Fremdsprachenkenntnisse in Englisch. Er hat eine Reihe von Mitgliedschaften in wissenschaftlichen Organisationen und eine Reihe von Zertifikaten und Auszeichnungen.